Image pharmaphorum Editor Views & Analysis How a flock of birds can help solve complex healthcare marke... Bilal Babar from THE PLANNING SHOP tells us how the movement of birds and Swarm Technology have helped develop multiple market research tools. White Papers Sponsored COVID-19’s lasting impact on digital communication in health... The ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic. Views & Analysis Why the next blockbuster in mental health might be a video g... David Keene looks at the difficulties faced in treating mental health patients and how digital technologies are changing the game. Views & Analysis Coronavirus pharma news roundup – 14/08/20 Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories. Load more results
Views & Analysis How a flock of birds can help solve complex healthcare marke... Bilal Babar from THE PLANNING SHOP tells us how the movement of birds and Swarm Technology have helped develop multiple market research tools.
White Papers Sponsored COVID-19’s lasting impact on digital communication in health... The ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic.
Views & Analysis Why the next blockbuster in mental health might be a video g... David Keene looks at the difficulties faced in treating mental health patients and how digital technologies are changing the game.
Views & Analysis Coronavirus pharma news roundup – 14/08/20 Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
